SCPHARMACEUTICALS INC. - COMMON STOCK

scPharmaceuticals to Announce Third Quarter 2023 Financial Results on Wednesday, November 8, 2023

01 Nov 2023 15:05:00 By Nasdaq GlobeNewswire

scPharmaceuticals to Participate in Two Upcoming Investor Conferences

31 Oct 2023 07:00:00 By Nasdaq GlobeNewswire

scPharmaceuticals Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

05 Oct 2023 07:00:00 By Nasdaq GlobeNewswire

scPharmaceuticals Announces Positive Feedback from Two FDA Meetings on Key Long-Term Growth Initiatives

19 Sep 2023 07:00:00 By Nasdaq GlobeNewswire

scPharmaceuticals to Present at the H.C. Wainwright 25th Annual Global Investment Conference

05 Sep 2023 07:00:01 By Nasdaq GlobeNewswire

scPharmaceuticals Inc. Reports Second Quarter 2023 Financial Results and Provides Business Update

10 Aug 2023 15:01:00 By Nasdaq GlobeNewswire

scPharmaceuticals to Announce Second Quarter 2023 Financial Results on Thursday, August 10, 2023

03 Aug 2023 07:00:00 By Nasdaq GlobeNewswire

scPharmaceuticals Announces Positive Type C Meeting Feedback from FDA on Potential Heart Failure Class IV Indication Expansion

01 Aug 2023 07:00:00 By Nasdaq GlobeNewswire

scPharmaceuticals Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

19 Jul 2023 07:00:01 By Nasdaq GlobeNewswire

scPharmaceuticals Inc. Announces Addition to Russell 2000® and Russell 3000® Indexes

23 Jun 2023 07:00:00 By Nasdaq GlobeNewswire

scPharmaceuticals to Present at the Jefferies Healthcare Conference

31 May 2023 07:00:00 By Nasdaq GlobeNewswire

scPharmaceuticals Inc. Reports First Quarter 2023 Financial Results and Provides Business Update

10 May 2023 15:01:00 By Nasdaq GlobeNewswire

scPharmaceuticals to Announce First Quarter 2023 Financial Results on Wednesday, May 10, 2023

02 May 2023 07:00:01 By Nasdaq GlobeNewswire

scPharmaceuticals Inc. Reports Fourth Quarter and Full-Year 2022 Financial Results and Provides Business Update

22 Mar 2023 15:05:00 By Nasdaq GlobeNewswire

scPharmaceuticals to Announce Fourth Quarter and Full-Year 2022 Financial Results on Wednesday, March 22

15 Mar 2023 07:00:00 By Nasdaq GlobeNewswire

scPharmaceuticals to Participate in the Cowen 43rd Annual Health Care Conference

23 Feb 2023 07:00:02 By Nasdaq GlobeNewswire

scPharmaceuticals Announces Launch and Commercial Availability of FUROSCIX® (furosemide injection)

21 Feb 2023 07:00:02 By Nasdaq GlobeNewswire

scPharmaceuticals Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

06 Feb 2023 07:00:00 By Nasdaq GlobeNewswire

scPharmaceuticals to Participate in the SVB Securities Global Biopharma Conference

31 Jan 2023 07:00:01 By Nasdaq GlobeNewswire

scPharmaceuticals Provides FUROSCIX® (furosemide injection) Commercial Update

30 Jan 2023 07:00:01 By Nasdaq GlobeNewswire